O6-methylguanine-dna-methyltransferase (mgmt) specific...

C - Chemistry – Metallurgy – 12 – P

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12P 21/08 (2006.01) C07K 16/40 (2006.01) C12N 5/18 (2006.01) C12N 9/10 (2006.01) G01N 33/573 (2006.01) G01N 33/574 (2006.01) G01N 33/577 (2006.01)

Patent

CA 2149867

2149867 9412660 PCTABS00032 The present invention provides antibodies capable of discriminating between native human MGMT and an active site alkylated form of this enzyme in an immunoprecipitation procedure. Monoclonal antibodies having such discriminating ability are obtainable from hybridoma ECACC 92112510 and hybridoma ECACC 93112514, which were deposited at the European Collection of Animal Cell Cultures, UK under the Budapest Treaty on 25th November 1992 and 25th November 1993 respectively. The monoclonal antibody of hybridoma ECACC 92112510 has been designated Mab 5H7. The monoclonal antibody of hybridoma ECACC 93112514 has been designated Mab 3C7.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

O6-methylguanine-dna-methyltransferase (mgmt) specific... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with O6-methylguanine-dna-methyltransferase (mgmt) specific..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and O6-methylguanine-dna-methyltransferase (mgmt) specific... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1886654

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.